Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

Comment by dardanion Aug 24, 2016 8:13pm
203 Views
Post# 25174232

RE:RE:Insiders are not sold !!!!!!!

RE:RE:Insiders are not sold !!!!!!! From the PLI board. Analyst doesn't think the 14 cent offer will be a problem for TST shareholders to accept. Might be a fait accompli if the under 14 cent shareholders don't ask for more.

[url= https://docdro.id/JuAekEC][/url]

Acquisition Supplements Cash And Future Manufacturing Capabilities - August 24, 2016


  Sep 30, 2016 – Mailing of circular to Telesta’s shareholders

  Oct 31, 2016 – Extraordinary meeting of Telesta’s shareholders

  Nov 7, 2016 – Court – Final order for plan of arrangement ratification

  Nov 10, 2016 – Closing and filing of articles of arrangement

The transaction should most likely close successfully, especially since we believe
that over 66 % of shares (the threshold of shareholder approval by shareholders

represented in person or by proxy at the shareholders’ meeting) purchased in the
last 12 months occurred at or below the $0.14 takeout price offered by PLI.
Furthermore, given the recent product development setback sustained by

Telesta, this transaction gives its shareholders an opportunity for exit and
<< Previous
Bullboard Posts
Next >>